Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Erlotinib can cause acne-like skin issues, needing early treatment and possible dosage adjustments.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A patient with complete hair loss regrew all her hair using tofacitinib.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Sorafenib and Platycladus orientalis leaf extract together effectively suppress cervical cancer cell growth.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tangent screens help detect visual field defects from vigabatrin.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Strontium ranelate is no longer available for treatment.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

TEDAR is crucial for skin cell differentiation and barrier formation.